Phase III trial presented at ASTRO in San Francisco finds five-treatment regimen poised to become new standard of care. SAN FRANCISCO, Sept. 29, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback